K john morrow jr (9 Ergebnisse)

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: As New. Unread book in perfect condition.

Paperback. Zustand: Brand New. 1st edition. 222 pages. 8.75x6.00x0.50 inches. In Stock.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: As New. Unread book in perfect condition.

Gebunden. Zustand: New. Cheng Liu, PhD, is founder and CEO of Eureka Therapeutics, a biotech company dedicated to monoclonal antibody drug discovery and development for unmet medical needs. He is an expert on therapeutic antibody and engineering, and a frequent speaker at pharmace.

Zustand: New. In English.

Buch. Zustand: Neu. Neuware - Addressing a significant need by describing the science and process involved to develop biosimilars of monoclonal antibody (mAb) drugs, this book covers all aspects of biosimilar development: preclinical, clinical, regulatory, manufacturing. - Guides readers through the complex landscape involved with developing biosimilar versions of monoclonal antibody (mAb) drugs- Features flow charts, tables, and figures that clearly illustrate processes and makes the book comprehensible and accessible- Includes a review of FDA-approved mAb drugs as a quick reference to facts and useful information- Examines new technologies and strategies for improving biosimilar mAbs.…

Zustand: New. Addressing a significant need by describing the science and process involved to develop biosimilars of monoclonal antibody (mAb) drugs, this book covers all aspects of biosimilar development: preclinical, clinical, regulatory, manufacturing. Editor(s): Liu, Cheng; Morrow, K. John, Jr. Num Pages: 704 pages. BIC Classification: PN; TDCW. Category: (P) Professional & Vocational. Dimension: 242 x 166 x 37. Weight in Grams: 1146. . 2016. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland. …